Dietary Composition for Appetite Suppression via Neurotransmitter Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obesity prevention and treatment, such as drug therapy, are challenging due to the need for prescription medications with potential side effects and the difficulty of maintaining exercise regimens, while dietary solutions lack effective appetite suppression and satiety mechanisms without relying on pharmaceuticals.
Innovation Solution
A dietary composition containing tryptophan, tyrosine, arginine, and whey protein as active ingredients, administered in specific weight percentages, which synthesizes neurotransmitters like serotonin, dopamine, and GLP-1 to induce appetite suppression and satiety, serving as a protein-rich meal replacement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If drug therapy (phentermine, SSRI, Saxenda) is used for appetite suppression, then appetite suppression efficacy is improved, but side effects and prescription requirements increase
Solution Approach 1:
The patent replaces expensive, prescription-required pharmaceuticals with a dietary composition containing amino acids (tryptophan, tyrosine, arginine) and whey protein that can be obtained through normal diet or supplements. These natural compounds temporarily boost neurotransmitter levels without the severe side effects of drugs like phentermine (psychotropic agent), Prozac (SSRI requiring prescription), or Saxenda (GLP-1 agonist requiring injection and prescription).
Solution Approach 2:
The patent uses dietary amino acids as intermediaries to indirectly achieve appetite suppression. Instead of directly administering pharmaceutical drugs that suppress appetite, the composition provides precursor amino acids that the body converts into neurotransmitters (serotonin from tryptophan, dopamine and norepinephrine from tyrosine, GLP-1 from arginine), which naturally regulate appetite and satiety.
2Use of energy by moving object
If exercise therapy is used for weight loss, then energy consumption is improved, but continuity and adherence worsen due to busy lifestyle
Solution Approach 1:
The patent creates a self-service solution where the dietary composition automatically provides appetite suppression and satiety effects through natural physiological pathways. The amino acids in the composition self-regulate neurotransmitter levels (serotonin, dopamine, norepinephrine, GLP-1) without requiring external motivation, discipline, or continuous exercise routines. The body's own neuroendocrine system does the work of regulating appetite when provided with these dietary precursors.
3Weight of moving object
If calorie intake is reduced for weight loss, then weight reduction is improved, but protein deficiency and nutrient lack worsen
Solution Approach 1:
The patent changes the nutritional parameters of the diet by emphasizing high-quality protein intake through whey protein (81-83% of the composition) combined with specific amino acids. This allows for reduced overall calorie intake while maintaining adequate protein levels, as the concentrated protein sources provide high protein content per calorie. The composition specifies precise amounts: 3.6-4.6 wt% tryptophan, 5-6 wt% tyrosine, 7.7-8.7 wt% arginine, and 81-83 wt% whey protein.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively promotes weight regulation and body fat reduction by enhancing appetite suppression and satiety without prescription medications, offering a safe and sustainable alternative for obesity management.
Implementation Method 1
tryptophan, which is one amino acid... synthesizes neurotransmitters like serotonin
Implementation Method 2
tyrosine... synthesizes neurotransmitters like serotonin, dopamine
Implementation Method 3
arginine... synthesizes neurotransmitters like serotonin, dopamine, and GLP-1
Data Source
AI summary
The present invention provides a method and a dietary composition for prevention and regulation of obesity capable of obtaining efficacy such as required appetite suppression or satiety by having a positive effect on concentrations of neurotransmitters such as serotonin, dopamine, and norepinephrine, and GLP-1 which are the principle of a mechanism of appetite inhibitory drugs without prescription of medicines (Phentermine, Prozac, Saxenda, etc.) and further being used as an alternative diet and supplying a protein that is the most lack ingredient during diet. The dietary composition includes tryptophan, which is one amino acid, tyrosine, which is the other amino acid, arginine, which is another amino acid, and a whey protein as active ingredients.